Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA
- 1 October 2014
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 211 (4) , 365.e1-365.e12
- https://doi.org/10.1016/j.ajog.2014.03.042
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical settingAmerican Journal of Obstetrics and Gynecology, 2011
- Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity studyBMJ, 2011
- Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasmaProceedings of the National Academy of Sciences, 2008
- Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal bloodProceedings of the National Academy of Sciences, 2008
- A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary studyThe Lancet, 2007
- Non‐invasive diagnosis of fetal sex; utilisation of free fetal DNA in maternal plasma and ultrasoundPrenatal Diagnosis, 2006
- Noninvasive Prenatal Diagnosis of Fetal Rhesus DObstetrics & Gynecology, 2005
- Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I dataPrenatal Diagnosis, 2002
- Prenatal DNA diagnosis of a single-gene disorder from maternal plasmaThe Lancet, 2000
- Presence of fetal DNA in maternal plasma and serumThe Lancet, 1997